Learn from others
The Corona Drug Survey aims to determine how the consumption of psychoactive substances has changed as a result of the COVID-19 pandemic (“corona crisis”). It investigates how the current situation affects the subjective experience and use of psychoactive substances.
The Corona Drug Survey is conducted by the Psychotropic Substances Group of Charité – Universitätsmedizin Berlin.
Participation in the survey is completely anonymous and no IP address is stored. It is therefore not possible for us to track who filled out the questionnaire.
Dr. Tomislav Majić
Head of Psychotropic Substances Research Group, St. Hedwig-Krankenhaus
Charité – Universitätsmedizin Berlin